Lindbrook Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $129K | Buy |
3,334
+416
| +14% | +$16.1K | 0.01% | 568 |
|
2024
Q4 | $98.7K | Sell |
2,918
-181
| -6% | -$6.12K | 0.01% | 564 |
|
2024
Q3 | $127K | Sell |
3,099
-491
| -14% | -$20.1K | 0.01% | 492 |
|
2024
Q2 | $138K | Sell |
3,590
-32
| -0.9% | -$1.23K | 0.01% | 444 |
|
2024
Q1 | $155K | Buy |
3,622
+568
| +19% | +$24.4K | 0.01% | 417 |
|
2023
Q4 | $113K | Buy |
3,054
+101
| +3% | +$3.74K | 0.01% | 487 |
|
2023
Q3 | $107K | Buy |
2,953
+987
| +50% | +$35.8K | 0.01% | 448 |
|
2023
Q2 | $70.1K | Sell |
1,966
-749
| -28% | -$26.7K | 0.01% | 596 |
|
2023
Q1 | $96.6K | Buy |
2,715
+150
| +6% | +$5.34K | 0.01% | 488 |
|
2022
Q4 | $90.1K | Buy |
2,565
+436
| +20% | +$15.3K | 0.01% | 517 |
|
2022
Q3 | $63K | Buy |
2,129
+468
| +28% | +$13.8K | 0.01% | 569 |
|
2022
Q2 | $90K | Buy |
1,661
+857
| +107% | +$46.4K | 0.01% | 464 |
|
2022
Q1 | $44K | Sell |
804
-245
| -23% | -$13.4K | 0.01% | 716 |
|
2021
Q4 | $58K | Sell |
1,049
-21
| -2% | -$1.16K | 0.01% | 668 |
|
2021
Q3 | $51K | Buy |
1,070
+65
| +6% | +$3.1K | 0.01% | 433 |
|
2021
Q2 | $50K | Buy |
1,005
+407
| +68% | +$20.2K | 0.01% | 480 |
|
2021
Q1 | $27K | Sell |
598
-465
| -44% | -$21K | 0.01% | 637 |
|
2020
Q4 | $49K | Buy |
1,063
+150
| +16% | +$6.91K | 0.01% | 404 |
|
2020
Q3 | $43K | Sell |
913
-560
| -38% | -$26.4K | 0.01% | 391 |
|
2020
Q2 | $75K | Sell |
1,473
-579
| -28% | -$29.5K | 0.02% | 264 |
|
2020
Q1 | $97K | Sell |
2,052
-1,804
| -47% | -$85.3K | 0.04% | 190 |
|
2019
Q4 | $226K | Sell |
3,856
-96
| -2% | -$5.63K | 0.08% | 125 |
|
2019
Q3 | $211K | Buy |
3,952
+613
| +18% | +$32.7K | 0.08% | 122 |
|
2019
Q2 | $167K | Buy |
3,339
+157
| +5% | +$7.85K | 0.06% | 154 |
|
2019
Q1 | $166K | Buy |
3,182
+822
| +35% | +$42.9K | 0.07% | 147 |
|
2018
Q4 | $112K | Buy |
+2,360
| New | +$112K | 0.06% | 176 |
|